US Stock MarketDetailed Quotes

SCPH scPharmaceuticals

Watchlist
  • 4.660
  • 0.0000.00%
Close May 3 16:00 ET
  • 4.660
  • 0.0000.00%
Post 16:02 ET
168.01MMarket Cap-3281P/E (TTM)

scPharmaceuticals Key Stats

scPharmaceuticals Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Mar 13, 2024

Revenue(YoY)

6.10M

0.00%
EPS(YoY)

-0.35

-16.67%

Strong Buy

Apr 30, 2024

scPharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 8.255M--
--2024/Q1-- / 5.977M--
Mar 13, 20242023/Q46.096M / 5.771M--
Nov 8, 20232023/Q33.796M / 3.420M--
Aug 10, 20232023/Q21.638M / 1.617M--
May 10, 20232023/Q12.063M / 1.572M--
Mar 22, 20232022/Q40.000 / 0.000--
Nov 9, 20222022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 8.255M--
--2024/Q1-- / 5.977M--
Mar 13, 20242023/Q46.096M / 5.771M--
Nov 8, 20232023/Q33.796M / 3.420M--
Aug 10, 20232023/Q21.638M / 1.617M--
May 10, 20232023/Q12.063M / 1.572M--
Mar 22, 20232022/Q40.000 / 0.000--
Nov 9, 20222022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--

Unlock Free Earnings Estimates

scPharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 30, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg